皇冠登录网址


A member of the company’s Senior Executive team, Mene has overall responsibility for the company’s pharmaceutical discovery research and early development activities.

Since joining AstraZeneca in 2010, Mene has been instrumental in rebuilding the company’s commitment to science and scientific excellence. He has led the transformation of R&D 产品介绍ivity; driven deeper collaborations with academic, biotech and peer organisations; pioneered programmes to promote Open Innovation and fostered a science driven culture that rewards great science and truth-seeking behaviours.

Mene retains an active interest in neurodegenerative disease and neuropharmacology and continues to mentor post docs and PhD students.

Mene has published 更多 than 140 peer-reviewed 文章s in scientific journals and is an internationally renowned expert in neuroscience and drug discovery. He is a leading figure in UK science, serving on several Boards including the Medical Research Council, the National Centre for Universities and Business Council, the Ministers and Industry Strategy Group and the Cambridge Biomedical Campus Strategy Board.

Mene is also overseeing the creation of AstraZeneca’s new £330 million research centre in Cambridge – a state of the art facility designed to stimulate collaborative scientific innovation and which will play an important role in the future success of the UK life science industry.

Our commitment is clear – fostering a culture that rewards pioneering science and asks the ‘killer’ questions. It’s how we push the boundaries of what’s possible.

Menelas Pangalos
皇冠登录网址

CURRENT ROLE

皇冠登录网址

TRANSFORMING R&D

皇冠登录网址

CREATING NEW R&D CENTRE

皇冠登录网址

PIONEERING INITIATIVES

皇冠登录网址

FOLLOWING THE SCIENCE

皇冠登录网址

  Featured publications
皇冠登录网址

皇冠登录网址

The GABAB2 subunit is essential for G protein coupling of the GABAB receptor heterodimer.皇冠登录网址

Robbins MJ, Calver AR, Fillipov AK, Couve A, Moss SJ and Pangalos MN. J. Neuroscience (2001) 21: 8043-8052.
http://www.jneurosci.org/content/21/20/8043.full.pdf

A role for cAMP dependent protein kinase phosphorylation in facilitating GABAB receptor effector coupling Nature Neuroscience (2002)皇冠登录网址

Couve A, Thomas P, Calver A, Hirst WD, Pangalos MN, Walsh FW, Smart T and Moss SJ. 5: 1-10.
http://www.nature.com/neuro/journal/v5/n5/full/nn833.html

Phospho-dependent functional modulation of GABAB receptors by the metabolic sensor AMP-dependent protein kinase. Neuron. 皇冠登录网址

Kuramoto N, Wilkins M, Fairfax B, Revilla-Sanchez R, Tamaki K, Couve A, Calver AR, Horvath Z, Freeman K, Carling D, Huang L, Cooper E, Gonlazes C, Cooper E, Smart TG, Pangalos MN, Moss SJ. (2007) 53:233-247.
http://www.cell.com/neuron/abstract/S0896-6273(06)01020-8

Prolonged activation of NMDA receptors induces dephosphorylation and degradation of GABAB receptors.皇冠登录网址

Terunuma M, Vargas KJ, Wilkins ME, Ramirez OA, Pangalos MN, Smart TG, Moss SJ and Couve A. PNAS (2010) 107(31):13918-23.
http://www.pnas.org/content/107/31/13918.full

Postsynaptic GABAB Receptor Activity Regulates Excitatory Neuronal Architecture and Spatial Memory.皇冠登录网址

Terunuma M, Revilla-Sanchez R, Quadros IM, Deng Q, Deeb TZ, Lumb M, Sicinski P, Haydon PG, Pangalos MN and Moss SJ. J Neurosci (2014) 34:804-816.
http://www.jneurosci.org/content/34/3/804.full.pdf

皇冠登录网址

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease.皇冠登录网址

Jacobsen JS, Wu C-C, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH and  Bloom FE. PNAS (2006) 103: 5161-5166.
http://www.pnas.org/content/103/13/516

Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. 皇冠登录网址

Jacobsen SJ, Comery TA, Marton RL, Elkodah H, Crandall DL, Oganesian A, Aschmies S, Kirksey Y, Gonzalez C, Xu J, Zaleska MM, Das I, Arias RL, Bard J, Riddell D, Gardell SJ, Abou-Gharbia M, Robichaud A, Magolda R, Vlasuk GP, Bjornsson T, Reinhart PH, Pangalos MN. PNAS (2008) 105: 8754-8759.
http://www.pnas.org/content/105/25/8754.ful

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.皇冠登录网址

Riddell DR, Kirksey Y, Hu Y, Warwick HK, Li Zhutting, Zhou H, Jacobsen JS, Pangalos MN and Reinhart PH and J Neurosci. (2008) 28(45):11445-11453.
http://www.jneurosci.org/content/28/45/11445.full.pdf

Amyloid based treatments for Alzheimer’s disease. In The Biology of Alzheimer’s Disease, edited by Holtzman D, Mandelkow E and Selkoe D皇冠登录网址

Basi G, Pangalos MN and Schenk D.  (2012) 423-454.


皇冠登录网址

What Is to Be Done? “Translational Neuroscience: Toward New Therapies” Strüngmann Forum Reports Series皇冠登录网址

Holtzman DM, Nikolich K, Pangalos MN, Broich K, Ip NY, Koo EH, Koroshetz WJ, Masliah E, Mucke L, Nicotera P, Schnaars M, Spillantini MG. Neurodegenerative Diseases;  ed. J. Lupp. Cambridge, MIT Press (2015).

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nature Drug Discovery皇冠登录网址

Cooke D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G and Pangalos MN. (2014) 13, 419–431.
http://www.nature.com/nrd/journal/v13/n6/full/nrd4309.html

Pioneering Government-Sponsored, Collaborative Drug Repositioning Initiatives: Progress and Learning. Nature Reviews Drug Discovery 皇冠登录网址

Frail D, Wegner C, Sanganee H, Brady M, Escott J, Pangalos MN, Holt A and Watkins C. (2015) in press.

永利皇冠app

皇冠登录网址

皇冠登录网址

皇冠官网注册

皇冠登录网址

皇冠登录网址

皇冠登录地址

皇冠登录网址

皇冠登录网址

皇冠登录网址

and help us deliver life-changing medicines 

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.